FDA to Issue Warning to Consuming Public About mRNA-based Vaccines: Higher Risk for Heart Inflammation

Hoag, Degenerative Mitral Valve Disease, Heart Health, Minimally Invasive, Jeffrey M. Carlton Heart and Vascular Institute,

Reuters reports that the U.S Food and Drug Administration (FDA) will move forward to include a warning concerning what at least initially include rare cases of heart inflammation observed in adolescents and young males to the pharmaceutical company fact sheets, including Pfizer-BioNTech and Moderna. TrialSite reported on a CDC warning involving myocarditis after the mRNA-based jabs and, based on other intelligence, TrialSite suspects further warnings could follow in the weeks and months to come.

Due to the recent CDC safety panel action assessing the “likely association” between the mRNA-based vaccines authorized on an emergency use basis and myocarditis and pericarditis in predominantly younger males, the FDA plans to “move rapidly” to insert a warning sheet to help protect the public

TrialSite has put forth the case that perhaps regulators should consider cutting back mRNA-based doses to just one.  A majority of adverse events, occurring after the second jab, but as described in this article the data reveals that the two-shot regimen reflected a specific way the trial data was presented. Would one dose have been sufficient?

Other breaking articles in TrialSite uncovered...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee